4.6 Article

Domain Structure of Lassa Virus L Protein

Journal

JOURNAL OF VIROLOGY
Volume 85, Issue 1, Pages 324-333

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00721-10

Keywords

-

Categories

Funding

  1. Vereinigung der Freunde des Tropeninstituts Hamburg e.V.
  2. European Union [LSHG-CT-2004-511960]
  3. German Research Foundation [GU 883/1-1]
  4. Bundesministerium fur Gesundheit
  5. Freie und Hansestadt Hamburg

Ask authors/readers for more resources

The 200-kDa L protein of arenaviruses plays a central role in viral genome replication and transcription. This study aimed at providing evidence for the domain structure of L protein by combining bioinformatics with a stepwise mutagenesis approach using the Lassa virus minireplicon system. Potential interdomain linkers were predicted using various algorithms. The prediction was challenged by insertion of flexible sequences into the predicted linkers. Insertion of 5 or 10 amino acid residues was tolerated at seven sites (S407, G446, G467, G774, G939, S1952, and V2074 in Lassa virus AV). At two of these sites, G467 and G939, L protein could be split into an N-terminal and a C-terminal part, which were able to trans-complement each other and reconstitute a functional complex upon coexpression. Coimmunoprecipitation studies revealed physical interaction between the N- and C-terminal domains, irrespective of whether L protein was split at G467 or G939. In confocal immunofluorescence microscopy, the N- terminal domains showed a dot-like, sometimes perinuclear, cytoplasmic distribution similar to that of full-length L protein, while the C-terminal domains were homogenously distributed in cytoplasm. The latter were redistributed into the dot-like structures upon coexpression with the corresponding N- terminal domain. In conclusion, this study demonstrates two interdomain linkers in Lassa virus L protein, at G467 and G939, suggesting that L protein is composed of at least three structural domains spanning residues 1 to 467, 467 to 939, and 939 to 2220. The first domain seems to mediate accumulation of L protein into cytoplasmic dot-like structures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Virus persistence after recovery from acute Lassa fever in Nigeria: a 2-year interim analysis of a prospective longitudinal cohort study

Anke Thielebein, Yemisi Ighodalo, Abubakar Taju, Thomas Olokor, Racheal Omiunu, Rita Esumeh, Paulson Ebhodaghe, Anieno Ekanem, Ganiyu Igenegbale, Rosemary Giwa, Annick Renevey, Julia Hinzmann, Jonas Mueller, Elisa Pallasch, Meike Pahlmann, Jeremie Guedj, Joy Nwatuzor, Oluwasola Femi Babatunde, Donatus Adomeh, Danny Asogun, Nosa Akpede, Sylvanus Okogbenin, Stephan Guenther, Lisa Oestereich, Sophie Duraffour, Ephraim Ogbaini-Emovon

Summary: The study found that Lassa virus RNA can be detected in various body fluids after recovery from acute Lassa fever, with the longest persistence in seminal fluid. The results showed that the persistence of viral RNA in seminal fluid was associated with higher viral load, severity of disease, and longer hospitalization during the acute phase of Lassa fever.

LANCET MICROBE (2022)

Article Infectious Diseases

Access and benefit-sharing by the European Virus Archive in response to COVID-19

Scarlett Sett, Carolina dos Santos Ribeiro, Christine Prat, George Haringhuizen, Amber Hartman Scholz

Summary: Biobanking infrastructures are crucial for early response to new viral outbreaks. The European Virus Archive played a key role in the global response to the COVID-19 pandemic, distributing viral resources for free and implementing benefit-sharing policies.

LANCET MICROBE (2022)

Article Virology

Detection of Lassa Virus-Reactive IgG Antibodies in Wild Rodents: Validation of a Capture Enzyme-Linked Immunological Assay

Hugo Soubrier, Umaru Bangura, Chris Hoffmann, Ayodeji Olayemi, Adetunji Samuel Adesina, Stephan Guenther, Lisa Oestereich, Elisabeth Fichet-Calvet

Summary: This study evaluated the use of a capture enzyme-linked immunosorbent assay (ELISA) for detecting LASV-reactive IgG antibodies in Mastomys rodents. The ELISA showed a high accuracy of 97.1% in known exposure samples and exhibited strong agreement with an immunofluorescence assay (IFA). It can be used as an alternative to IFA for determining LASV IgG serostatus in Mastomys rodents.

VIRUSES-BASEL (2022)

Article Immunology

Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria

Mirjam Groger, Peter Akhideno, Christine J. Kleist, Femi O. Babatunde, Osahogie Edeawe, Julia Hinzmann, ThankGod Akhigbe, Joy Nwatuzor, Gloria Eifediyi, Jonas Mueller, Mette Hinrichs, Meike Pahlmann, Francisca Naana Sarpong, Christine Wagner, Anke Thielebein, Louis Aihonwalan, Till Koch, Maria Riedner, Ephraim Ogbaini-Emovon, Sylvanus Okogbenin, Stephan Guenther, Sebastian G. Wicha, Michael Ramharter, Lisa Oestereich, Sophie Duraffour, Cyril Erameh

Summary: This study examines the pharmacokinetics of ribavirin in the treatment of Lassa fever and finds consistent exposure across patients. While ribavirin shows low antiviral efficacy, it may have anti-inflammatory effects. Further research is needed to determine the role of ribavirin in the treatment of Lassa fever.

CLINICAL INFECTIOUS DISEASES (2023)

Letter Medicine, General & Internal

Detection of Marburg Virus Disease in Guinea

Fara R. Koundouno, Liana E. Kafetzopoulou, Martin Faye, Annick Renevey, Barre Soropogui, Kekoura Ifono, Emily V. Nelson, Aly A. Kamano, Charles Tolno, Giuditta Annibaldis, Saa L. Millimono, Jacob Camara, Karifa Kourouma, Ahmadou Dore, Tamba E. Millimouno, Fernand M. B. Tolno, Julia Hinzmann, Hugo Soubrier, Mette Hinrichs, Anke Thielebein, Glaucia Herzer, Meike Pahlmann, Georges A. Ki-Zerbo, Pierre Formenty, Anais Legand, Michael R. Wiley, Ousmane Faye, Moussa M. Diagne, Amadou A. Sall, Philippe Lemey, Aissatou Bah, Stephan Guenther, Sakoba Keita, Sophie Duraffour, N'Faly Magassouba

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report

Jennifer Cable, Anthony Fauci, William E. Dowling, Stephan Guenther, Dennis A. Bente, Pragya Dhruv Yadav, Lawrence C. Madoff, Lin-Fa Wang, Rahul K. Arora, Maria Van Kerkhove, May C. Chu, Thomas Jaenisch, Jonathan H. Epstein, Simon David William Frost, Daniel G. Bausch, Lisa E. Hensley, Eric Bergeron, Ioannis Sitaras, Michael D. Gunn, Thomas W. Geisbert, Cesar Munoz-Fontela, Florian Krammer, Emmie de Wit, Pontus Nordenfelt, Erica Ollmann Saphire, Sarah C. Gilbert, Kizzmekia S. Corbett, Luis M. Branco, Sylvain Baize, Neeltje van Doremalen, Marco A. Krieger, Sue Ann Costa Clemens, Renske Hesselink, Dan Hartman

Summary: The importance of maintaining and strengthening investments in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, etc. during the COVID-19 pandemic to enable quick, concerted responses to future threats, especially to zoonotic pathogens, was emphasized during a symposium gathering researchers from various sectors.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2022)

Article Virology

Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors

Monika Rottstegge, Tom Tipton, Lisa Oestereich, Paula Ruibal, Emily Nelson, Catherine Olal, Julia R. Port, Johan Seibel, Elisa Pallasch, Sabrina Bockholt, Fara Raymond Koundouno, Joseph Akoi Bore, Estefania Rodriguez, Beatriz Escudero-Perez, Stephan Guenther, Miles W. Carroll, Cesar Munoz-Fontela

Summary: Ebola virus disease (EVD) is a complex infectious disease characterized by high inflammation, multiorgan failure, dysregulation of immune responses, and coagulation abnormalities. The interaction between T cells and antigen-presenting cells (APC) plays a crucial role in the pathogenesis of EVD. Transplantation of T cells and APCs from survivors can protect against EVD in a mouse avatar model.

JOURNAL OF VIROLOGY (2022)

Article Virology

Understanding Host-Virus Interactions: Assessment of Innate Immune Responses in Mastomys natalensis Cells after Arenavirus Infection

Nele Marie Brinkmann, Chris Hoffmann, Stephanie Wurr, Elisa Pallasch, Julia Hinzmann, Eleonore Ostermann, Wolfram Brune, Maria Elisabeth Eskes, Lukas Jungblut, Stephan Guenther, Ludmilla Unrau, Lisa Oestereich

Summary: The study suggests that the type I interferon response is not a major factor in the virus-host barrier for arenaviruses in Mastomys natalensis cells.

VIRUSES-BASEL (2022)

Article Microbiology

An introduction to the Marburg virus vaccine consortium, MARVAC

Robert W. Cross, Ira M. Longini, Stephan Becker, Karin Bok, David Boucher, Miles W. Carroll, Janet Diaz, William E. Dowling, Ruxandra Draghia-Akli, James T. Duworko, John M. Dye, Michael A. Egan, Patricia Fast, Amy Finan, Courtney Finch, Thomas R. Fleming, Joan Fusco, Thomas W. Geisbert, Anthony Griffiths, Stephan Guenther, Lisa E. Hensley, Anna Honko, Ruth Hunegnaw, Jocelyn Jakubik, Julie Ledgerwood, Kerstin Luhn, Demetrius Matassov, Jeffrey Meshulam, Emily Nelson, Christopher L. Parks, Roxana Rustomjee, David Safronetz, Lauren M. Schwartz, Dean Smith, Paul Smock, Ydrissa Sow, Christina F. Spiropoulou, Nancy J. Sullivan, Kelly L. Warfield, Daniel Wolfe, Courtney Woolsey, Roland Zahn, Ana Maria Henao-Restrepo, Cesar Munoz-Fontela, Andrea Marzi

Summary: This article discusses the current progress, challenges, and future directions of MARV vaccines, as well as the formation of the MARVAC consortium to respond to the threat of this infectious disease.

PLOS PATHOGENS (2022)

Article Virology

2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

Jens H. Kuhn, Scott Adkins, Sergey Alkhovsky, Tatjana Avsic-Zupanc, Maria A. Ayllon, Justin Bahl, Anne Balkema-Buschmann, Matthew J. Ballinger, Martina Bandte, Martin Beer, Nicolas Bejerman, Eric Bergeron, Nadine Biedenkopf, Laurent Bigarre, Carol D. Blair, Kim R. Blasdell, Steven B. Bradfute, Thomas Briese, Paul A. Brown, Remy Bruggmann, Ursula J. Buchholz, Michael J. Buchmeier, Alexander Bukreyev, Felicity Burt, Carmen Buettner, Charles H. Calisher, Thierry Candresse, Jeremy Carson, Inmaculada Casas, Kartik Chandran, Remi N. Charrel, Yuya Chiaki, Anya Crane, Mark Crane, Laurent Dacheux, Elena Dal Bo, Juan Carlos de la Torre, Xavier de Lamballerie, William M. de Souza, Rik L. de Swart, Nolwenn M. Dheilly, Nicholas Di Paola, Francesco Di Serio, Ralf G. Dietzgen, Michele Digiaro, J. Felix Drexler, W. Paul Duprex, Ralf Duerrwald, Andrew J. Easton, Toufc Elbeaino, Koray Ergunay, Guozhong Feng, Claudette Feuvrier, Andrew E. Firth, Anthony R. Fooks, Pierre B. H. Formenty, Juliana Freitas-Astua, Selma Gago-Zachert, Maria Laura Garcia, Adolfo Garcia-Sastre, Aura R. Garrison, Scott E. Godwin, Jean-Paul J. Gonzalez, Joelle Gouy de Bellocq, Anthony Grifths, Martin H. Groschup, Stephan Gunther, John Hammond, Jussi Hepojoki, Melanie M. Hierweger, Seiji Hongo, Masayuki Horie, Hidenori Horikawa, Holly R. Hughes, Adam J. Hume, Timothy H. Hyndman, Daohong Jiang, Gilda B. Jonson, Sandra Junglen, Fujio Kadono, David G. Karlin, Boris Klempa, Jonas Klingstrom, Michel C. Koch, Hideki Kondo, Eugene Koonin, Jarmila Krasova, Mart Krupovic, Kenji Kubota, Ivan Kuzmin, Lies Laenen, Amy J. Lambert, Jianrong Li, Jun-Min Li, Francois Liefrig, Igor S. Lukashevich, Dongsheng Luo, Piet Maes, Marco Marklewitz, Sergio H. Marshall, Shin-Yi L. Marzano, John W. McCauley, Ali Mirazimi, Peter G. Mohr, Nick J. G. Moody, Yasuaki Morita, Richard N. Morrison, Elke Muhlberger, Rayapati Naidu, Tomohide Natsuaki, Jose A. Navarro, Yutaro Neriya, Sergey Netesov, Gabriele Neumann, Norbert Nowotny, Francisco M. Ochoa-Corona, Gustavo Palacios, Laurane Pallandre, Vicente Pallas, Anna Papa, Sofa Paraskevopoulou, Colin R. Parrish, Alex Pauvolid-Correa, Janusz T. Paweska, Daniel R. Perez, Florian Pfaf, Richard K. Plemper, Thomas S. Postler, Francoise Pozet, Sheli R. Radoshitzky, Pedro L. Ramos-Gonzalez, Marius Rehanek, Renato O. Resende, Carina A. Reyes, Victor Romanowski, Dennis Rubbenstroth, Luisa Rubino, Artemis Rumbou, Jonathan A. Runstadler, Melanie Rupp, Sead Sabanadzovic, Takahide Sasaya, Heike Schmidt-Posthaus, Martin Schwemmle, Torsten Seuberlich, Stephen R. Sharpe, Mang Shi, Manuela Sironi, Sophie Smither, Jin-Won Song, Kirsten M. Spann, Jessica R. Spengler, Mark D. Stenglein, Ayato Takada, Robert B. Tesh, Jana Tesikova, Natalie J. Thornburg, Nicole D. Tischler, Yasuhiro Tomitaka, Keizo Tomonaga, Noel Tordo, Kenta Tsunekawa, Massimo Turina, Ioannis E. Tzanetakis, Anna Maria Vaira, Bernadette van den Hoogen, Bert Vanmechelen, Nikos Vasilakis, Martin Verbeek, Susanne von Bargen, Jiro Wada, Victoria Wahl, Peter J. Walker, Anna E. Whitfeld, John Williams, Yuri Wolf, Junki Yamasaki, Hironobu Yanagisawa, Gongyin Ye, Yong-Zhen Zhang, Arnfnn Lodden Okland

Summary: This article presents the updated taxonomy of Negarnaviricota, including the addition of new families, genera, and species, renaming and moving of species, and correction of misspelled names as accepted by the International Committee on Taxonomy of Viruses (ICTV).

ARCHIVES OF VIROLOGY (2022)

Article Multidisciplinary Sciences

A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol

Suzanne N. Penfold, Ayola Akim A. Adegnika, Danny F. Asogun, Olufemi Ayodeji, Benedict Azuogu, William A. Fischer, Robert Garry, Donald Samuel Grant, Christian Happi, Magassouba A. N'Faly, Adebola Olayinka, Robert Samuels, Jefferson Sibley, David Wohl, Manfred Accrombessi, Ifedayo Adetifa, Giuditta Annibaldis, Anton Camacho, Chioma Dan-Nwafor, Akpene Ruth Esperencia Deha, Jean DeMarco, Sophie Duraffour, Augustine Goba, Rebecca Grais, Stephan Guenther, Enagnon Junior Juvenal Prince Honvou, Chikwe Ihekweazu, Christine Jacobsen, Lansana Kanneh, Mambu Momoh, Aminata Ndiaye, Robert Nsaibirni, Sylvanus Okogbenin, Chinwe S. Ochu, Ephraim Ogbaini, Enagnon Parsifal Marie Alexandre Logbo, John Demby Sandi, John Schieffelin, Thomas Verstraeten, Nathalie Vielle, Anges Yadouleton, Emmanuel Koffi Yovo

Summary: Lassa fever, caused by Lassa fever virus (LASV), is endemic in West Africa and causes 5000 fatalities each year. The aim of the Enable Lassa research programme is to estimate the incidences of LASV infection and LF disease in five West African countries. The core protocol harmonises key study components to ensure data comparability for between-country analyses.

PLOS ONE (2023)

Article Infectious Diseases

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study

Nzelle Delphine Kayem, Sylvanus Okogbenin, Joseph Okoeguale, Joseph Eigbefoh, Joseph Ikheloa, Reuben Eifediyi, Xavier Enodiana, Olugbenga Emmanuel Olorogbogo, Isoken Aikpokpo, Yemisi Ighodalo, Thomas Olokor, George Odigie, Lyndsey Castle, Sophie Duraffour, Lisa Oestereich, Prabin Dahal, Proochista Ariana, Stephan Gunther, Peter Horby

Summary: This study aims to evaluate the efficiency of transplacental transfer of Lassa virus antibodies from mother to child. The study demonstrates that maternal antibody levels play a crucial role in determining the transfer efficiency and may be influenced by the timing of antibody development. The study suggests that vaccination before pregnancy, in women of childbearing age, may be more appropriate for protecting both pregnant women and their neonates.

PLOS NEGLECTED TROPICAL DISEASES (2023)

Article Infectious Diseases

Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study

Nzelle Delphine Kayem, Sylvanus Okogbenin, Joseph Okoeguale, Mojeed Momoh, Antonia Njoku, Reuben Eifediyi, Xavier Enodiana, Hilary Ngwu, Wilfred Irhiogbe, Yemisi Ighodalo, Thomas Olokor, George Odigie, Lyndsey Castle, Sophie Duraffour, Lisa Oestereich, Prabin Dahal, Proochista Ariana, Stephan Gunther, Peter Horby

Summary: This study evaluated the epidemiology of Lassa fever in pregnant women in South Nigeria and found that about 50% of pregnant women had Lassa virus antibodies, indicating a high risk of Lassa infection during pregnancy. It also suggested that 35.0% of infections could be prevented by avoiding rodent exposure and conditions that facilitate infestation. Public health measures such as improved sanitation and hygiene could be beneficial in reducing the risk of infection.

PLOS NEGLECTED TROPICAL DISEASES (2023)

Article Immunology

Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea

Stephanie Longet, Cristina Leggio, Joseph Akoi Bore, Stephanie Key, Tom Tipton, Yper Hall, Fara Raymond Koundouno, Hilary Bower, Tapan Bhattacharyya, N'Faly Magassouba, Stephan Guenther, Ana-Maria Henao-Restrapo, Jeremy S. Rossman, Mandy Kader Konde, Kimberly Fornace, Miles W. Carroll

Summary: The exposure to Lassa fever virus (LASV) showed heterogeneity in different ecological regions of Guinea, with seropositivity rates of 11.9% in coastal areas and 59.6% in forested areas. There were significant associations between LASV exposure risk and landscape fragmentation in coastal and forested regions. This study highlights the potential link between environmental change and LASV emergence, emphasizing the urgent need for research on land management practices that reduce disease risks.

EMERGING INFECTIOUS DISEASES (2023)

Article Immunology

Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections

Sylvanus Okogbenin, Cyril Erameh, Joseph Okoeguale, Osahogie Edeawe, Esele Ekuaze, Kelly Iraoyah, John Agho, Mirjam Groger, Benno Kreuels, Lisa Oestereich, Femi O. Babatunde, Peter Akhideno, Stephan Gunther, Michael Ramharter, Till Omansen

Summary: This study reported successful remission of complicated Lassa fever in two patients in Nigeria, who received the anti-inflammatory agent dexamethasone and standard ribavirin treatment.

EMERGING INFECTIOUS DISEASES (2022)

No Data Available